Related Experiment Video

Updated: Jul 31, 2026

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging
08:30

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging

Published on: September 11, 2011

Lightening the lead load in children

M R Ellis1, K Y Kane

  • 1University of Missouri-Columbia School of Medicine, USA.

American Family Physician
|August 19, 2000
PubMed

Insights

Elevated blood lead levels in children are linked to IQ decline. Current treatments focus on reducing blood lead, but more research is needed on patient outcomes like IQ.

Area of Science:

  • Pediatric Environmental Health
  • Toxicology
  • Public Health

Background:

  • Over 4% of US preschool children have blood lead levels exceeding 10 µg/dL, associated with cognitive deficits.
  • The CDC recommends screening questionnaires for early detection of lead exposure.
  • Primary prevention (removing lead from gasoline/paint) and secondary prevention (paint hazard remediation) have reduced childhood lead levels.

Purpose of the Study:

  • To review current strategies for identifying and managing childhood lead exposure.
  • To evaluate the effectiveness of existing treatments for lead toxicity.
  • To highlight the need for research on patient-oriented outcomes.

Main Methods:

  • Review of current guidelines and literature on lead screening and treatment.
  • Analysis of primary and secondary prevention strategies.
  • Discussion of chelation therapies (DMSA, CaNa2EDTA, BAL) for elevated lead levels.

Main Results:

  • Screening questionnaires are advocated for identifying children at risk.
  • Chelation therapy is recommended for specific blood lead level thresholds.
  • Current treatments primarily aim to lower blood lead levels.

Conclusions:

  • Existing lead removal strategies have been effective but challenges remain.
  • Current treatment protocols may not fully address the overall lead burden.
  • Further clinical trials are essential to assess patient-centered outcomes, including IQ improvement.

More Related Videos

Measuring Cardiac Autonomic Nervous System (ANS) Activity in Toddlers - Resting and Developmental Challenges08:22

Measuring Cardiac Autonomic Nervous System (ANS) Activity in Toddlers - Resting and Developmental Challenges

Published on: February 25, 2016

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level05:35

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

Published on: January 19, 2024

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.